Disease spotlight: Duchenne muscular dystrophy (DMD)Duchenne muscular dystrophy (DMD) is a genetic disorder characterised by progressive muscle degeneration and weakness.Duchenne is a rare Share XDisease spotlight: Duchenne muscular dystrophy (DMD)https://pharmaphorum.com/views-and-analysis/duchenne-muscular-dystrophy/
Disease spotlight: LHONLeber’s hereditary optic neuropathy (LHON) is a rare, progressive, hereditary condition that leads to blindness in young adults.The Share XDisease spotlight: LHONhttps://pharmaphorum.com/views-and-analysis/therapy-area-spotlight/
CAR-Ts dominated the agenda at ASH 2017The American Society for Hematology congress was dominated by CAR-T therapies – their potential new uses, how to Share XCAR-Ts dominated the agenda at ASH 2017https://pharmaphorum.com/views-analysis-oncology/car-ts-dominated-agenda-ash-2017/
11/23/2017The evolution of pharma social media intelligenceIs your company a fully mature user of intelligence from social media, or is it still not tapping Share XThe evolution of pharma social media intelligencehttps://pharmaphorum.com/debates-insight-sales-marketing/evolution-pharma-social-media-intelligence/
